Treatment & Vaccine

Moderna’s vaccine candidate employs genetic material extracted from the virus, known as viral mRNA.

Moderna Shares Its COVID Vaccine Trial Plan: What You Should Know

COVID Vaccine To Be Available By Start of 2021: Harsh Vardhan

Two indigenous vaccines by Zydus Cadila and Bharat Biotech have completed phase 1 trials.

Russia to Sell COVID-19 Vaccine to Dr Reddy’s Lab

Sputnik V was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund.

Novavax To Produce 2 Bn Doses of COVID Vaccine With New India Deal

US vaccine developer Novavax on Tuesday said that it planned to double it manufacturing capacity for the COVID-19 vaccine.

SII Gets Nod To Resume Trials For Oxford COVID-19 Vaccine in India

The DCGI has revoked its order to suspend all new recruitment for phase two and phase three trials.

UK Researchers To Test Effectiveness of Inhaled Vaccines

Researchers in Britain are planning to examine whether inhaled coronavirus vaccines work better than if they were injected.

SII may also partner with Russia’s Gamaleya Research Institute to manufacture the Sputnik V vaccine, according to recent reports.

There Won’t Be Enough COVID Vaccines Till 2024: Adar Poonawalla

India May Fast Track COVID-19 Vaccine for High Risk Groups: Govt

COVID-19: Pfizer Vaccine May Be Available To Americans By Year End

The experimental vaccine was administered on monkeys, and induced a strong immune response in them, protecting them from the viral infection.

COVID-19 Vaccine: India’s Covaxin Shows Efficacy in Animal Trials 

AstraZeneca Resumes Oxford COVID Vaccine Trials in UK 

SII to Suspend Recruitment for COVID Vaccine Trial For Now: DCGI  

Moderna’s vaccine candidate employs genetic material extracted from the virus, known as viral mRNA.

Moderna Shares Its COVID Vaccine Trial Plan: What You Should Know

COVID Vaccine To Be Available By Start of 2021: Harsh Vardhan

Two indigenous vaccines by Zydus Cadila and Bharat Biotech have completed phase 1 trials.

Russia to Sell COVID-19 Vaccine to Dr Reddy’s Lab

Sputnik V was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund.
US vaccine developer Novavax on Tuesday said that it planned to double it manufacturing capacity for the COVID-19 vaccine.

Novavax To Produce 2 Bn Doses of COVID Vaccine With New India Deal

SII Gets Nod To Resume Trials For Oxford COVID-19 Vaccine in India

The DCGI has revoked its order to suspend all new recruitment for phase two and phase three trials.

UK Researchers To Test Effectiveness of Inhaled Vaccines

Researchers in Britain are planning to examine whether inhaled coronavirus vaccines work better than if they were injected.
SII may also partner with Russia’s Gamaleya Research Institute to manufacture the Sputnik V vaccine, according to recent reports.

There Won’t Be Enough COVID Vaccines Till 2024: Adar Poonawalla

India May Fast Track COVID-19 Vaccine for High Risk Groups: Govt

An emergency authorisation can be considered once a certain degree of efficacy and safety is proven, officials say.

COVID-19: Pfizer Vaccine May Be Available To Americans By Year End

Pfizer shares their vaccine is going to be available hopefully by the end of the year.
The experimental vaccine was administered on monkeys, and induced a strong immune response in them, protecting them from the viral infection.

COVID-19 Vaccine: India’s Covaxin Shows Efficacy in Animal Trials 

AstraZeneca Resumes Oxford COVID Vaccine Trials in UK 

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK.

SII to Suspend Recruitment for COVID Vaccine Trial For Now: DCGI  

SII has also been asked to increase the safety monitoring of the subjects already vaccinated as part of the trial.